Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril-valsartan versus valsartan for hypertension in patients with aortic dissection
ChiCTR2300073399Phase 4Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypertension (HTN) comparing Valsartan group with Sacubitril-valsartan group (2 arms). Primary endpoint: Decrease in mean sitting systolic blood pressure from baseline. Started Sep 2021; status: completed.
02
Drugs
sacubitril + valsartanvalsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2300073399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073399.